0001493152-23-017322 Sample Contracts

10% PROMISSORY NOTE

Convertible Security Agreement • May 15th, 2023 • Propanc Biopharma, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Convertible Security Agreement
• Filed
  May 15th, 2023
• Company
  Propanc Biopharma, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

THIS IS A 10% PROMISSORY NOTE of Propanc Biopharma, Inc. (the “Company”), a Delaware Corporation, having its principal place of business at 302. 6 Butler Street, Camberwell, VIC 3124, Australia (this “Note”), which represents a duly authorized and validly issued debt of the Company.

SECURITIES PURCHASE AGREEMENT

Securities Purchase Agreement • May 15th, 2023 • Propanc Biopharma, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Securities Purchase Agreement
• Filed
  May 15th, 2023
• Company
  Propanc Biopharma, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of November 3, 2022 between Propanc Biopharma, Inc. a Delaware corporation (the “Company”), and Coventry Enterprises, LLC, a Delaware limited liability company (“Investor”).

COMMON STOCK PURCHASE AGREEMENT

Common Stock Purchase Agreement • May 15th, 2023 • Propanc Biopharma, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Common Stock Purchase Agreement
• Filed
  May 15th, 2023
• Company
  Propanc Biopharma, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This Common Stock Purchase Agreement (the “Agreement”) is entered into as of November 3, 2022, by and between PROPANC BIOPHARMA INC., a Delaware corporation (the “Company”), and COVENTRY ENTERPRISES, LLC, a Delaware limited liability company (the “Investor”). The Company and Investor may be referred to herein as each a ‘‘Party” and collectively, the “Parties”.

REGISTRATION RIGHTS AGREEMENT

Registration Rights Agreement • May 15th, 2023 • Propanc Biopharma, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Registration Rights Agreement
• Filed
  May 15th, 2023
• Company
  Propanc Biopharma, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This Registration Rights Agreement (this “Agreement”), dated as of November 3, 2022, by and between PROPANC BIOPHARMA, INC., a Delaware corporation (the “Company”), and Coventry Enterprises, LLC, a Delaware limited liability company (together with it permitted assigns, the “Investor”) (the Company and Investor each a “Party” and together the “Parties”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Common Stock Purchase Agreement by and between the Parties, dated as of the date hereof (as amended, restated, supplemented, or otherwise modified from time to time, the “Purchase Agreement”).